Cytotherapy

Insights from CTTACC: immune system reset by cellular therapies for chronic illness after trauma, infection, and burn.

Cytotherapy

Bertram K, Cox C, Alam H, Lowell C, Cuschieri J, Parekkadan B, Pati S

Fludarabine-exposure predicts disease control following CD19-specific car t cell (tisagenlecleucel); a report from pediatric real-world car consortium.

Cytotherapy

K.J. Curran, V.A. Fabrizio, A. Mauguen, J.J. Boelens, C. Baggott, S. Prabhu, H. Placenta, C.L. Phillips, J. Rossoff, H. Stefanski, J. Talano, A. Moskop, S.P. Margossian, M.R. Verneris, G. Myers, N.A. Karras, P.A. Brown, M. Qayed, M. Hermiston, P. Satwani, C. Krupski, A. Keating, R. Wilcox, C.A. Rabik, V. Chinnabhandar, M. Kunicki, A. Goksenin, C. Mackall, T.W. Laetsch, L.M. Schultz

Accelerating the development of innovative cellular therapy products for the treatment of cancer.

Cytotherapy

Stewart MD, Keane A, Butterfield LH, Levine BL, Thompson B, Xu Y, Ramsborg C, Lee A, Kalos M, Koerner C, Moore T, Markovic I, Lasiter L, Ibrahim R, Bluestone J, Sigal E, Allen J

LB47 Making multiple therapeutic cell products from a cGMP-compliant iPSC line.

Cytotherapy

Xianmin Zeng, Ying Pei, Helen Cifuentes, Thelma Garcia, Deepak Lamba, Mahendra Rao

Pages